Published in Postgrad Med J on February 01, 2000
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med (1996) 6.05
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med (1983) 6.00
Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med (1984) 5.02
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med (1985) 2.99
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet (1989) 2.97
Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA (1997) 2.93
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation (1996) 1.75
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation (1999) 1.59
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study. Circulation (1996) 1.53
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med (1991) 1.33
Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor. Blood (1985) 1.13
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. Circulation (1995) 1.03
Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation (1999) 1.03
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group. Circulation (1994) 0.92
The anti-GPIIb-IIIa agents: fundamental and clinical aspects. Haemostasis (1996) 0.82
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation (1996) 0.82
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. J Am Coll Cardiol (1996) 0.81
Stenting in Acute Myocardial Infarction: Observational Studies and Randomized Trials Ñ 1998. J Invasive Cardiol (1998) 0.81
Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy. Am J Cardiol (1985) 0.80
Antiplatelet therapy following stent deployment. Heart (1997) 0.77
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene (2001) 2.22
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
Anticoagulation for cardioversion of atrial arrhythmias. Eur Heart J (1998) 1.54
Left main intervention revisited: early and late outcome of PTCA and stenting. Cathet Cardiovasc Diagn (1997) 1.50
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr Mol Med (2009) 1.50
Sexual behaviour, drug use and hepatitis B infection in Chandigarh students. Natl Med J India (1996) 1.48
Rate or rhythm control in persistent atrial fibrillation? QJM (2003) 1.47
Angioplasty and acute myocardial infarction. Lancet (1993) 1.40
Anti-thrombotic therapy for non-rheumatic atrial fibrillation. QJM (1996) 1.39
Pulmonary embolism-an update on thrombolytic therapy. QJM (2000) 1.38
Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol (1996) 1.35
Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology (2003) 1.29
Chemotaxis of a Ralstonia sp. SJ98 toward different nitroaromatic compounds and their degradation. Biochem Biophys Res Commun (2000) 1.19
Percutaneous coronary intervention: recommendations for good practice and training. Heart (2005) 1.14
Antiplatelet rather than anticoagulant therapy with coronary stenting. Lancet (1997) 1.08
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol (2001) 1.05
The aspirin papers. BMJ (1994) 1.03
Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol (2001) 1.03
Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun (1999) 1.02
Chemotaxis and biodegradation of 3-methyl- 4-nitrophenol by Ralstonia sp. SJ98. Biochem Biophys Res Commun (2000) 1.01
Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry (1996) 1.01
A rare coronary anatomy comprising dual (Type IV) left anterior descending arteries and an anomalous left circumflex artery from the right coronary artery. J Invasive Cardiol (2011) 1.01
Kinetics of biodegradation of p-nitrophenol by different bacteria. Biochem Biophys Res Commun (2000) 1.00
Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry (2013) 0.99
Plasmid-encoded degradation of p-nitrophenol by Pseudomonas cepacia. Biochem Biophys Res Commun (1996) 0.97
Do Indo-Asians have smaller coronary arteries? Postgrad Med J (1999) 0.96
Treatment of myocardial infarction. BMJ (1998) 0.95
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet (1995) 0.93
Antibodies to hepatitis C virus in blood donors. Indian J Gastroenterol (1992) 0.93
Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Brain Res (2000) 0.92
Activation of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. Biochem Biophys Res Commun (1993) 0.90
Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England. Heart (2005) 0.88
Lesson of the week. Unrecognised accidental overdose with diltiazem. BMJ (2000) 0.87
Insulin initiation and management in people with Type 2 diabetes in an ethnically diverse population: the healthcare provider perspective. Diabet Med (2012) 0.87
Higher energy monophasic DC cardioversion for persistent atrial fibrillation: is it time to start at 360 joules? Ann Noninvasive Electrocardiol (2003) 0.86
An unusual presentation of delayed cardiac perforation caused by atrial screw-in lead. Heart (2003) 0.85
Hepatitis E virus: epidemiological, clinical and serological studies of north Indian epidemic. Indian J Gastroenterol (1994) 0.85
Phosphoinositide-dependent in vitro phosphorylation of profilin by protein kinase C. Phospholipid specificity and localization of the phosphorylation site. Recept Signal Transduct (1996) 0.83
Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. Thorax (2008) 0.82
Impairment of coronary flow reserve in orthotopic cardiac transplant recipients with minor coronary occlusive disease. Br Heart J (1992) 0.82
A new medium for rapid slide culture of tubercle bacilli. Indian J Pathol Microbiol (1993) 0.82
Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparin. Int J Cardiol (1993) 0.82
Effect of cholesterol on Ca2+-induced aggregation of liposomes and calcium diphosphatidate membrane traversal. Biochemistry (1986) 0.82
Iatrogenic left coronary artery dissection. Heart (2003) 0.82
The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin times. Blood Coagul Fibrinolysis (1993) 0.81
Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro. Thromb Res (1993) 0.81
Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent (2000) 0.81
Oscillations in free [Ca2+]i during early cell division cycles in Xenopus laevis embryos. Biol Bull (1994) 0.80
Modulation of cytokine production from an EpiOcular corneal cell culture model in response to Staphylococcus aureus superantigen. Aust N Z J Ophthalmol (1997) 0.80
Binding of amyloid beta-protein to intracellular brain proteins in rat and human. Neurochem Res (1998) 0.80
Occlusive systolic bridging of circumflex artery. Catheter Cardiovasc Interv (2000) 0.80
Fibrillar amyloid beta-protein forms a membrane-like hydrophobic domain. Neuroreport (2001) 0.78
Insulin resistance in syndrome X. Lancet (1993) 0.78
Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis (1992) 0.78
Effect of lysozyme on adhesion and toxin release by Staphylococcus aureus. Aust N Z J Ophthalmol (1999) 0.78
Presentations of pyogenic liver abscess in one UK centre over a 15-year period. J R Coll Physicians Edinb (2011) 0.77
Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty. Atherosclerosis (1996) 0.77
Selective targeting of habenular, thalamic midline and monoaminergic brainstem neurons by neurotropic influenza A virus in mice. J Neurovirol (1999) 0.77
Magnesium protects phosphatidylinositol-4,5-bisphosphate-mediated inactivation of casein kinase I in erythrocyte membrane. Biochim Biophys Acta (1993) 0.77
Effect of thyroxine on fibrinolytic system in rat. Indian J Physiol Pharmacol (2013) 0.77
Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome. Coron Artery Dis (1993) 0.77
Seasonal Variation in Essential Oil Content and Composition of Thyme, Thymus serpyllum L. Cultivated in Uttarakhand Hills. Indian J Pharm Sci (2011) 0.77
Promotion of synthetic amyloid beta-peptide fibrillization by cell culture media and cessation of fibrillization by serum. Neurosci Lett (1996) 0.77
Factors secreted by activated microglia and monocytes reduce amyloidogenesis in vascular smooth muscle cells. Neuroreport (1997) 0.76
Tonsillectomy and adenoidectomy for obstructive sleep apnea in sickle cell anemia. Indian J Pediatr (2010) 0.76
The effect of water hydraulic permeability on the settling of a soft contact lens on the eye. Curr Eye Res (2005) 0.76
Prevention and management of bleeding complications after thrombolysis. Int J Cardiol (1993) 0.76
Differential effects of spermine on phosphatidylinositol 3-kinase and phosphatidylinositol phosphate 5-kinase. Life Sci (1995) 0.76
Interaction of protein kinase C and phosphoinositides: regulation by polyamines. Cell Signal (1994) 0.76
Chemical investigation of the essential oil of Thymus linearis (Benth. ex Benth) from western Himalaya, India. Nat Prod Res (2010) 0.75
Dressler's syndrome following pulmonary vein isolation for atrial fibrillation. Acute Card Care (2008) 0.75
Neurostimulation and myocardial ischaemia. Br Heart J (1994) 0.75
The role of coronary angioplasty and stenting in acute myocardial infarction. Postgrad Med J (1999) 0.75
Lipid activators of protein kinase C. Life Sci (1990) 0.75
Spinal cord stimulation and coronary ischaemia. BMJ (1993) 0.75
The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time. Postgrad Med J (1994) 0.75
Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese. J Vasc Res (1993) 0.75
Acute cerebral artery occlusion and thrombolytic therapy. Lancet (1992) 0.75
Syndrome X: an abnormality of epicardial or microvascular coronary circulation? J Am Coll Cardiol (1994) 0.75
Tacrolimus and cardiotoxicity in adult liver transplant recipients. Lancet (1995) 0.75
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad Med J (2005) 0.75
Antiplatelet therapy following coronary artery surgery. J R Soc Med (1994) 0.75
Pulmonary embolism--the role of thrombolytic therapy in its management. Postgrad Med J (1996) 0.75
Tricuspid aortic valve aneurysm. Heart (2005) 0.75
A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation. Heart (2004) 0.75
Acute heart retransplantation. Lancet (1991) 0.75
The stimulation by adrenocorticotropin of the phosphorylation of adrenal inhibitor-1: a possible role in steroidogenesis. Mol Cell Endocrinol (1988) 0.75
Coronary artery bypass grafting nine years after cardiac transplantation. Ann Thorac Surg (1992) 0.75
Preparation of passive bilayer liposomes. Chem Phys Lipids (1988) 0.75
Regulation of high molecular weight bovine brain neutral protease by phospholipids in vitro. Mol Cell Biochem (2005) 0.75
Can beta blockers be safely initiated at home in patients with heart failure? QJM (2002) 0.75
Targeting fibrinolytic agents to the vessel wall: a new therapeutic niche? Thromb Haemost (1994) 0.75
Changes in renal function with percutaneous transluminal coronary angioplasty. Int J Cardiol (1999) 0.75
Effect of locally applied tissue-type plasminogen activator on venous fibrinolytic activity: in vitro and in vivo investigations. Cardiovasc Res (1993) 0.75
Acute myocardial infarction in angiographically normal coronary arteries following induction of general anesthesia. Arch Intern Med (1994) 0.75
Failed thrombolysis in myocardial infarction. Int J Cardiol (2000) 0.75